The shrinking lungs syndrome in systemic lupus erythematosus

Mayo Clinic Proceedings

Volumn 75, Issue 5, 2000, Pages 467-472

  Warrington, Kenneth J ^a,b   Moder, Kevin G ^a,b,c   Mark Brutinel, W ^a,b,c  

^a Division of Hematology and Internal Medicine   (United States)

^b Division of Pulmonary   (United States)

^c MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DNA ANTIBODY; MUSCLE ENZYME; OXYGEN; PREDNISONE; SALBUTAMOL; SURFACTANT; THEOPHYLLINE;

ARTIFICIAL VENTILATION; CLINICAL FEATURE; DYSPNEA; HEMIDIAPHRAGM; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; PROGNOSIS; REVIEW; SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY;

EID: 0034065604     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.5.467     Document Type: Review

References (26)

1. Orens JB, Martinez FJ, Lynch JP III. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am. 1994;20:159-193.
2. Ropes MW. Systemic Lupus Erythematosus. Cambridge, Mass: Harvard University Press; 1976.
3. Hoffbrand BI, Beck ER. "Unexplained" dyspnoea and shrinking lungs in systemic lupus erythematosus. BMJ. 1965;1:1273-1277.
4. Gibson CJ, Edmonds JP, Hughes GR. Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med. 1977; 63:926-932.
5. Martens J, Demedts M, Vanmeenen MT, Dequeker J. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest. 1983; 84:170-175.
6. Stevens WM, Burdon JG, Clemens LE, Webb J. The "shrinking lungs syndrome"-an infrequently recognised feature of systemic lupus erythematosus. Aust NZJ Med. 1990;20:67-70.
7. Thompson PJ, Dhillon DP, Ledingham J, Turner-Warwick M. Shrinking lungs, diaphragmatic dysfunction, and systemic lupus erythematosus. Am Rev Respir Dis. 1985; 132:926-928.
8. Laroche CM, Mulvey DA, Hawkins PN, et al. Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q JMed. 1989;71:429-439.
9. Pines A, Kaplinsky N, Olchovsky D, Rozenman J, Frankl O. Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups: prognostic and therapeutic implications. Chest. 1985;88:129-135.
10. Walz-Leblanc B A, Urowitz MB, Gladman DD, Hanly PJ. The "shrinking lungs syndrome" in systemic lupus erythematosusimprovement with corticosteroid therapy. J Rheumatol. 1992; 19: 1970-1972.
11. Soubrier M, Dubost JJ, Piette JC, et al. Shrinking lung syndrome in systemic lupus erythematosus: a report of three cases. Rev Rhum EnglEd. 1995;62:395-398.
12. Van Veen S, Peelers AJ, Sterk PJ, Breedveld FC. The "shrinking lung syndrome" in SLE, treatment with theophylline. Clin Rheumatol. 1993; 12:462-465.
13. Munoz-Rodriguez FJ, Font J, Badia JR, et al. Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy. Lupus. 1997;6:412-414.
14. Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE-a clinical pathologic study. JRheumatol. 1983; 10:973-976.
15. Jacobelli S, Moreno R, Massardo L, Rivero S, Lisboa C. Inspiratory muscle dysfunction and unexplained dyspnea in systemic lupus erythematosus. Arthritis Rheum. 1985;28:781-788.
16. Wilcox PG, Stein HB, Clarke SD, Pare PD, Pardy RL. Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus. Chest. 1988;93:352-358.
17. De Troyer A, Estenne M. Limitations of measurement of transdiaphragmatic pressure in detecting diaphragmatic weakness. Thorax. 1981;36:169-174.
18. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore). 1954;33: 291-437.
19. Tumulty PA. The clinical course of systemic lupus erythematosus. JAMA. 1954; 156:947-953.
20. Ellman P, Cudkowicz L. Pulmonary manifestations in the diffuse collagen diseases. Thorax. 1954;9:46-57.
21. Aubier M. Effect of theophylline on diaphragmatic muscle function. Chest. 1987;92(suppl 1):27S-31S.
22. Aubier M, Viires N, Murciano D, Medrano G, Lecocguic Y, Pariente R. Effects and mechanism of action of terbutaline on diaphragmatic contractility and fatigue. J Appl Physiol. 1984;56: 922-929.
23. Bernstein RM, Ind PW, Elkon KB, et al. Pulmonary function in SLE with a longitudinal study of the shrinking lungs syndrome [abstract]. Arthritis Rheum. 1982;25(suppl):S7.
24. Gibson GJ. Diaphragmatic paresis: pathophysiology, clinical features, and investigation. Thorax. 1989;44:960-970.
25. Laroche CM, Green M. Diaphragmatic paresis: pathophysiology, clinical features, and investigation [letter]. Thorax. 1990;45:302303.
26. Gibson GJ. Author's reply. Thorax. 1990;45:303.